UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 ORor 15(d) of The

~~the~~ Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~August~~November 278, 2012

AMERICAN RENAL HOLDINGS INC.

(Exact ~~name~~Name of ~~registrant~~Registrant as ~~specified~~Specified in ~~its~~Its ~~charter~~Charter)

Delaware	333-170376	04-3477845
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

500 Cummings Center

Beverly, Massachusetts 01915

(Address of Principal Executive Office)

Registrant’s telephone number, including area code (978) 922-3080

66 Cherry Hill Drive

Beverly, Massachusetts 01915

(Address of Principal Executive Offices)

Registrant’s telephone number, including area code: (978) 992-3080

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12(b))

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~Item 1~~ITEM 2.0102 ~~Entry~~Results ~~into~~of aOperations ~~Material~~and ~~Definitive~~Financial ~~Agreement~~Condition.

OnThe ~~August 27,~~information ~~2012,~~contained ~~American~~in Renal Holdings Intermediate Company, LLC (“Holdings”), American Renal Holdings Inc. (the “Borrower”), certain lenders, and Bank of America, N.A., as the administrative agent (the “Administrative Agent”), entered into Amendment No.Item ~~2 (“Amendment No~~7. ~~2”)~~01 ~~amending the Credit Agreement, dated as~~ of ~~May 7,~~this ~~2010~~Current ~~(as~~Report ~~amended by Amendment No. 1~~ on ~~June 3,~~Form ~~2010,~~8-K ~~the~~is ~~“Credit~~incorporated ~~Agreement”)~~by ~~among~~reference ~~Holdings, Borrower, the lending institutions identified~~ in ~~the~~this ~~Credit Agreement and the Administrative Agent in order to increase the combined commitments of such lending institutions from $25,000,000~~Item 2.~~00 to $37,500,000~~02.~~00 and decrease the applicable rate of interest.~~

~~Item 2~~ITEM 7.0301 ~~Creation~~Regulation ofFD aDisclosure. ~~Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant~~

ToOn November 8, 2012, American Renal Holdings Inc., a Delaware corporation (the ~~extent~~“Company”), ~~required~~announced byits ~~Item~~financial results for the quarter ended September 230, 2012.03 A copy of the Company’s earnings press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K, ~~the~~and ~~information~~incorporated ~~set~~by ~~forth~~reference ~~under~~in this Item 17.01. ~~above~~The isinformation ~~hereby~~contained ~~incorporated~~in ~~into~~ this ~~Item 2~~Current Report on Form 8-K, including Exhibit 99.031, shall not be deemed “filed” with the Securities and Exchange Commission nor incorporated by reference in any registration statement filed by the Company under the Securities Act of 1933, as amended.

~~SIGNATURE~~ITEM 9.01. Financial Statements and Exhibits.

~~Pursuant~~(d) ~~to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized~~Exhibits.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	AMERICAN RENAL HOLDINGS INC.

Date: November 8, 2012	By:	/s/ Michael R. Costa
		Michael R. Costa
		Vice President, General Counsel and Secretary

EXHIBIT INDEX


Exhibit Number		Description

99.1		Press Release, dated November 8, 2012.

Date: August 30, 2012

AMERICAN RENAL HOLDINGS INC.

ExhibitNumber

Description

/s/ Michael R. Costa

Press Release, dated November 8, 2012.

Michael R. Costa

Vice President, General Counsel and Secretary

Filing Compare · American Renal Holdings Inc.